High-performance liquid chromatographic analysis of zolmitriptan in human plasma using fluorescence detection

被引:47
作者
Chen, J [1 ]
Jiang, XG [1 ]
Jiang, WM [1 ]
Mei, N [1 ]
Gao, XL [1 ]
Zhang, QZ [1 ]
机构
[1] Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 200032, Peoples R China
关键词
zolmitriptan; high-performance liquid chromatography (HPLC);
D O I
10.1016/j.jpba.2004.01.019
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple, rapid and sensitive high-performance liquid chromatographic (HPLC) method has been developed to quantify zolmitriptan in plasma using an isocratic system with fluorescence detection. The method included a single-step liquid-liquid extraction with methyl tertiary butyl ether. HPLC separation was carried out by reversed phase chromatography with a mobile phase composed of 0.05% (v/v) triethylamine in water(adjusting to pH 2.75 with 85% phosphoric acid) and acetonitrile (92:8, v/v), pumped at flow rate of 1.5 ml/min. Fluorescence detection was performed at 225 nm (excitation) and 360 urn (emission). The calibration curve for zolmitriptan was linear from 0.2 to 40 ng/ml. The validation method yielded good results regarding linearity, precision, accuracy, specificity and recoveries. The values of the limit of detection (LOD) and limit of quantification (LOQ) were 20 and 40 pg, respectively. The method was sensitive, simple and repeatable enough to be used in pharmacokinetic studies. (C) 2004 Elsevier B.V. All fights reserved.
引用
收藏
页码:639 / 645
页数:7
相关论文
共 7 条
[1]   Simultaneous measurement of zolmitriptan and its major metabolites N-desmethylzolmitriptan and zolmitriptan N-oxide in human plasma by high-performance liquid chromatography with coulometric detection [J].
Clement, EM ;
Franklin, M .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 766 (02) :339-343
[2]   The clinical pharmacokinetics of zolmitriptan [J].
Dixon, R ;
Warrander, A .
CEPHALALGIA, 1997, 17 :15-20
[3]  
DOWSON AJ, 2002, EXPERT OPIN PHARMACO, V7, P993
[4]   The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers [J].
Seaber, EJ ;
Peck, RW ;
Smith, DA ;
Allanson, J ;
Hefting, NR ;
van Lier, JJ ;
Sollie, FAE ;
Wemer, J ;
Jonkman, JHG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (05) :433-439
[5]   Pharmacokinetics and pharmacodynamics of zolmitriptan in patients with mild to moderate hypertension: A double-blind, placebo-controlled study [J].
Smith, DA ;
Cleary, EW ;
Watkins, S ;
Huffman, CS ;
Dilzer, SC ;
Lasseter, KC .
JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (08) :685-693
[6]  
Vishwanathan K, 2000, RAPID COMMUN MASS SP, V14, P168, DOI 10.1002/(SICI)1097-0231(20000215)14:3<168::AID-RCM861>3.0.CO
[7]  
2-9